Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

PET-CT Scanning Market by Application (Oncology, Neurology, Cardiology, Others) and by Service Provider (Hospitals, Diagnostic Centers, Research Institutes): Global Opportunity Analysis and Industry Forecast, 2023-2032

A02388

Pages: NA

Charts: NA

Tables: NA

Positron emission tomography-computed tomography (PET-CT) is a medical analytical technique used to examine the metabolic activity of tissues. This technique makes the use of PET scanner and an X-ray CT scanner. The PET scanners are used to measure body functions, such as blood flow, oxygen usage, and glucose metabolism, whereas CT imaging uses X-ray equipment to produce pictures of organs to observe the functioning of tissues and organs. The combined use of PET-CT scans provides the images of precise location of abnormal metabolic activity in the body.

The global PET-CT scanning market is segmented based on application, service provider, and geography. Applications covered in this study include oncology, neurology, cardiology, and others. On the basis of service provider, the market is categorized into hospitals, diagnostic centers, and research institutes. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The growth of the global PET-CT scanning market is driven by rise in prevalence of chronic illnesses throughout the world, growth in demand for effective diagnostic systems, and increased coverage for PET-CT scanning under Medicare. Rise in use of PET-CT for cancer diagnosis is expected to further boost the market growth. Moreover, development of newer products and increase in investments in R&D by companies contribute towards the revenue growth of the market. However, limited shelf life and inadequate availability of radiopharmaceuticals are expected to hinder the market growth.

Comprehensive competitive analysis and profiles of major market players such as Toshiba Corporation, General Electric Co, Hitachi, Siemens AG, Positron Corporation, Yangzhou Kindsway Biotech Co. Ltd, and Mediso Ltd are provided in this report.

Key Benefits

  • This report offers a detailed quantitative analysis of the current market trends to identify the prevailing opportunities.
  • The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
  • The global market is analyzed with respect to application, service provider, and geography.
  • In-depth analysis based on geography facilitates to analyze the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Key Market Segments

  • By Application
    • Oncology
    • Neurology
    • Cardiology
    • Others
  • By Service Provider
    • Hospitals
    • Diagnostic Centers
    • Research Institutes
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • General Electric Co.
  • Koninklijke Philips N.V.
  • Mediso Ltd.
  • Canon Inc.
  • Toshiba Corporation
  • Positron Corporation
  • Hitachi
  • Neusoft Corporation
  • MinFound Medical Systems Co. Ltd.
  • Siemens AG
  • Yangzhou Kindsway Biotech Co. Ltd.
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: PET-CT SCANNING MARKET, BY APPLICATION

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Application

    • 4.2. Oncology

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Neurology

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Cardiology

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Others

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: PET-CT SCANNING MARKET, BY SERVICE PROVIDER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Service Provider

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Diagnostic Centers

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Research Institutes

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: PET-CT SCANNING MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Application

      • 6.2.3. Market Size and Forecast, By Service Provider

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Pet-ct Scanning Market

        • 6.2.5.1. Market Size and Forecast, By Application
        • 6.2.5.2. Market Size and Forecast, By Service Provider
      • 6.2.6. Canada Pet-ct Scanning Market

        • 6.2.6.1. Market Size and Forecast, By Application
        • 6.2.6.2. Market Size and Forecast, By Service Provider
      • 6.2.7. Mexico Pet-ct Scanning Market

        • 6.2.7.1. Market Size and Forecast, By Application
        • 6.2.7.2. Market Size and Forecast, By Service Provider
    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Application

      • 6.3.3. Market Size and Forecast, By Service Provider

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Pet-ct Scanning Market

        • 6.3.5.1. Market Size and Forecast, By Application
        • 6.3.5.2. Market Size and Forecast, By Service Provider
      • 6.3.6. Germany Pet-ct Scanning Market

        • 6.3.6.1. Market Size and Forecast, By Application
        • 6.3.6.2. Market Size and Forecast, By Service Provider
      • 6.3.7. Italy Pet-ct Scanning Market

        • 6.3.7.1. Market Size and Forecast, By Application
        • 6.3.7.2. Market Size and Forecast, By Service Provider
      • 6.3.8. Spain Pet-ct Scanning Market

        • 6.3.8.1. Market Size and Forecast, By Application
        • 6.3.8.2. Market Size and Forecast, By Service Provider
      • 6.3.9. UK Pet-ct Scanning Market

        • 6.3.9.1. Market Size and Forecast, By Application
        • 6.3.9.2. Market Size and Forecast, By Service Provider
      • 6.3.10. Russia Pet-ct Scanning Market

        • 6.3.10.1. Market Size and Forecast, By Application
        • 6.3.10.2. Market Size and Forecast, By Service Provider
      • 6.3.11. Rest Of Europe Pet-ct Scanning Market

        • 6.3.11.1. Market Size and Forecast, By Application
        • 6.3.11.2. Market Size and Forecast, By Service Provider
    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Application

      • 6.4.3. Market Size and Forecast, By Service Provider

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Pet-ct Scanning Market

        • 6.4.5.1. Market Size and Forecast, By Application
        • 6.4.5.2. Market Size and Forecast, By Service Provider
      • 6.4.6. Japan Pet-ct Scanning Market

        • 6.4.6.1. Market Size and Forecast, By Application
        • 6.4.6.2. Market Size and Forecast, By Service Provider
      • 6.4.7. India Pet-ct Scanning Market

        • 6.4.7.1. Market Size and Forecast, By Application
        • 6.4.7.2. Market Size and Forecast, By Service Provider
      • 6.4.8. South Korea Pet-ct Scanning Market

        • 6.4.8.1. Market Size and Forecast, By Application
        • 6.4.8.2. Market Size and Forecast, By Service Provider
      • 6.4.9. Australia Pet-ct Scanning Market

        • 6.4.9.1. Market Size and Forecast, By Application
        • 6.4.9.2. Market Size and Forecast, By Service Provider
      • 6.4.10. Thailand Pet-ct Scanning Market

        • 6.4.10.1. Market Size and Forecast, By Application
        • 6.4.10.2. Market Size and Forecast, By Service Provider
      • 6.4.11. Malaysia Pet-ct Scanning Market

        • 6.4.11.1. Market Size and Forecast, By Application
        • 6.4.11.2. Market Size and Forecast, By Service Provider
      • 6.4.12. Indonesia Pet-ct Scanning Market

        • 6.4.12.1. Market Size and Forecast, By Application
        • 6.4.12.2. Market Size and Forecast, By Service Provider
      • 6.4.13. Rest of Asia Pacific Pet-ct Scanning Market

        • 6.4.13.1. Market Size and Forecast, By Application
        • 6.4.13.2. Market Size and Forecast, By Service Provider
    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Application

      • 6.5.3. Market Size and Forecast, By Service Provider

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Pet-ct Scanning Market

        • 6.5.5.1. Market Size and Forecast, By Application
        • 6.5.5.2. Market Size and Forecast, By Service Provider
      • 6.5.6. South Africa Pet-ct Scanning Market

        • 6.5.6.1. Market Size and Forecast, By Application
        • 6.5.6.2. Market Size and Forecast, By Service Provider
      • 6.5.7. Saudi Arabia Pet-ct Scanning Market

        • 6.5.7.1. Market Size and Forecast, By Application
        • 6.5.7.2. Market Size and Forecast, By Service Provider
      • 6.5.8. UAE Pet-ct Scanning Market

        • 6.5.8.1. Market Size and Forecast, By Application
        • 6.5.8.2. Market Size and Forecast, By Service Provider
      • 6.5.9. Argentina Pet-ct Scanning Market

        • 6.5.9.1. Market Size and Forecast, By Application
        • 6.5.9.2. Market Size and Forecast, By Service Provider
      • 6.5.10. Rest of LAMEA Pet-ct Scanning Market

        • 6.5.10.1. Market Size and Forecast, By Application
        • 6.5.10.2. Market Size and Forecast, By Service Provider
  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Toshiba Corporation

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. General Electric Co.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Hitachi

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Siemens AG

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Positron Corporation

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Yangzhou Kindsway Biotech Co. Ltd.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Mediso Ltd.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Koninklijke Philips N.V.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Canon Inc.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Neusoft Corporation

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

    • 8.11. MinFound Medical Systems Co. Ltd.

      • 8.11.1. Company Overview

      • 8.11.2. Key Executives

      • 8.11.3. Company Snapshot

      • 8.11.4. Operating Business Segments

      • 8.11.5. Product Portfolio

      • 8.11.6. Business Performance

      • 8.11.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PET-CT SCANNING MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL PET-CT SCANNING MARKET FOR ONCOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL PET-CT SCANNING MARKET FOR NEUROLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL PET-CT SCANNING MARKET FOR CARDIOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL PET-CT SCANNING MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL PET-CT SCANNING MARKET, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL PET-CT SCANNING MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL PET-CT SCANNING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL PET-CT SCANNING MARKET FOR RESEARCH INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL PET-CT SCANNING MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA PET-CT SCANNING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 14. U.S. PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 15. U.S. PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 16. CANADA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 17. CANADA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 19. MEXICO PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE PET-CT SCANNING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 24. FRANCE PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. GERMANY PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 27. ITALY PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. ITALY PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. SPAIN PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 31. UK PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. UK PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. RUSSIA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. REST OF EUROPE PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC PET-CT SCANNING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 40. CHINA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 41. CHINA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 43. JAPAN PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 44. INDIA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. INDIA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. SOUTH KOREA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. AUSTRALIA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. THAILAND PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. MALAYSIA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. INDONESIA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA PET-CT SCANNING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. BRAZIL PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH AFRICA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. SAUDI ARABIA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 67. UAE PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. UAE PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. ARGENTINA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA PET-CT SCANNING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. REST OF LAMEA PET-CT SCANNING, BY SERVICE PROVIDER, 2025-2033 ($MILLION)
  • TABLE 73. TOSHIBA CORPORATION: KEY EXECUTIVES
  • TABLE 74. TOSHIBA CORPORATION: COMPANY SNAPSHOT
  • TABLE 75. TOSHIBA CORPORATION: OPERATING SEGMENTS
  • TABLE 76. TOSHIBA CORPORATION: PRODUCT PORTFOLIO
  • TABLE 77. TOSHIBA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. GENERAL ELECTRIC CO.: KEY EXECUTIVES
  • TABLE 79. GENERAL ELECTRIC CO.: COMPANY SNAPSHOT
  • TABLE 80. GENERAL ELECTRIC CO.: OPERATING SEGMENTS
  • TABLE 81. GENERAL ELECTRIC CO.: PRODUCT PORTFOLIO
  • TABLE 82. GENERAL ELECTRIC CO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. HITACHI: KEY EXECUTIVES
  • TABLE 84. HITACHI: COMPANY SNAPSHOT
  • TABLE 85. HITACHI: OPERATING SEGMENTS
  • TABLE 86. HITACHI: PRODUCT PORTFOLIO
  • TABLE 87. HITACHI: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. SIEMENS AG: KEY EXECUTIVES
  • TABLE 89. SIEMENS AG: COMPANY SNAPSHOT
  • TABLE 90. SIEMENS AG: OPERATING SEGMENTS
  • TABLE 91. SIEMENS AG: PRODUCT PORTFOLIO
  • TABLE 92. SIEMENS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. POSITRON CORPORATION: KEY EXECUTIVES
  • TABLE 94. POSITRON CORPORATION: COMPANY SNAPSHOT
  • TABLE 95. POSITRON CORPORATION: OPERATING SEGMENTS
  • TABLE 96. POSITRON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 97. POSITRON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. YANGZHOU KINDSWAY BIOTECH CO. LTD.: KEY EXECUTIVES
  • TABLE 99. YANGZHOU KINDSWAY BIOTECH CO. LTD.: COMPANY SNAPSHOT
  • TABLE 100. YANGZHOU KINDSWAY BIOTECH CO. LTD.: OPERATING SEGMENTS
  • TABLE 101. YANGZHOU KINDSWAY BIOTECH CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 102. YANGZHOU KINDSWAY BIOTECH CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. MEDISO LTD.: KEY EXECUTIVES
  • TABLE 104. MEDISO LTD.: COMPANY SNAPSHOT
  • TABLE 105. MEDISO LTD.: OPERATING SEGMENTS
  • TABLE 106. MEDISO LTD.: PRODUCT PORTFOLIO
  • TABLE 107. MEDISO LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 109. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 110. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
  • TABLE 111. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 112. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. CANON INC.: KEY EXECUTIVES
  • TABLE 114. CANON INC.: COMPANY SNAPSHOT
  • TABLE 115. CANON INC.: OPERATING SEGMENTS
  • TABLE 116. CANON INC.: PRODUCT PORTFOLIO
  • TABLE 117. CANON INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. NEUSOFT CORPORATION: KEY EXECUTIVES
  • TABLE 119. NEUSOFT CORPORATION: COMPANY SNAPSHOT
  • TABLE 120. NEUSOFT CORPORATION: OPERATING SEGMENTS
  • TABLE 121. NEUSOFT CORPORATION: PRODUCT PORTFOLIO
  • TABLE 122. NEUSOFT CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. MINFOUND MEDICAL SYSTEMS CO. LTD.: KEY EXECUTIVES
  • TABLE 124. MINFOUND MEDICAL SYSTEMS CO. LTD.: COMPANY SNAPSHOT
  • TABLE 125. MINFOUND MEDICAL SYSTEMS CO. LTD.: OPERATING SEGMENTS
  • TABLE 126. MINFOUND MEDICAL SYSTEMS CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 127. MINFOUND MEDICAL SYSTEMS CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PET-CT SCANNING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PET-CT SCANNING MARKET
  • FIGURE 3. SEGMENTATION PET-CT SCANNING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PET-CT SCANNING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPET-CT SCANNING MARKET
  • FIGURE 11. PET-CT SCANNING MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 12. PET-CT SCANNING MARKET FOR ONCOLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. PET-CT SCANNING MARKET FOR NEUROLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. PET-CT SCANNING MARKET FOR CARDIOLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. PET-CT SCANNING MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. PET-CT SCANNING MARKET SEGMENTATION, BY BY SERVICE PROVIDER
  • FIGURE 17. PET-CT SCANNING MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. PET-CT SCANNING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. PET-CT SCANNING MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: PET-CT SCANNING MARKET
  • FIGURE 26. TOP PLAYER POSITIONING, 2024
  • FIGURE 27. TOSHIBA CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. TOSHIBA CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. TOSHIBA CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. GENERAL ELECTRIC CO.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. GENERAL ELECTRIC CO.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. GENERAL ELECTRIC CO.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. HITACHI: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. HITACHI: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. HITACHI: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. SIEMENS AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. SIEMENS AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. SIEMENS AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. POSITRON CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. POSITRON CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. POSITRON CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. YANGZHOU KINDSWAY BIOTECH CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. YANGZHOU KINDSWAY BIOTECH CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. YANGZHOU KINDSWAY BIOTECH CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. MEDISO LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. MEDISO LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. MEDISO LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. KONINKLIJKE PHILIPS N.V.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. CANON INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. CANON INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. CANON INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. NEUSOFT CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. NEUSOFT CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. NEUSOFT CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. MINFOUND MEDICAL SYSTEMS CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. MINFOUND MEDICAL SYSTEMS CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. MINFOUND MEDICAL SYSTEMS CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
PET-CT Scanning Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue